We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership with us. “We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas...

Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later this year for validation of the Antibody-Catch.™ Download the press release here. ...

We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing an entirely novel concept in cancer therapeutics, aiming to generate novel anti-cancer agents targeting circulating tumor cell clusters, leading to...

From our partner, KPGM: Proving an online knowledge base for the COVID-19 times.  KPMG has put together an online resource page for these challenging and uncertain times. The resources include:  -  A Covid-19 legal Hotline, where you can ask your legal questions and get free advice-  Recent...

Anaveon, a Basel-based immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund, and joined by the Novartis Venture Fund. The company was founded with financing from BaseLaunch, the healthcare accelerator of BaselArea.swiss in December 2017 and...

Polyneuron Pharmaceuticals, one of our portfolio companies has successfully raised 22.5 million francs in a round of financing. The Basel-based company will use the proceeds to launch its first in-human clinical trial with its lead product for the treatment of the autoimmune disease Anti-MAG Peripheral...

The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners and BB Pureos Bioventures and joined by BPI France, Schröder Adveq and the HTGF. Alentis develops therapeutics in advanced liver disease and cancer. BaseLaunch, a healthcare accelerator operated by...